Cite
HARVARD Citation
O'Neil, B. et al. (n.d.). A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer. Annals of oncology. p. 1180. [Online].